Project Grant HT94252410555
Award Date
9/30/24
Completion Date
9/29/26
Dollars Obligated
$366K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Tacoma, WA 98402, USA
Similar Awards
The Geneva Foundation was awarded a $362,100 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program to conduct research toward the dual targeting of HER2 and androgen receptor in patients with high-risk, hormone-naive prostate cancer with curative intent. The two-year grant project period runs from June 1, 2022 to May 31, 2024. Through this funding, The Geneva Foundation will perform applied medical research investigating...
The Department of the Army's Military Medical Research and Development program (CFDA 12.420) awarded a $1,009,750 Project Grant to The Geneva Foundation, a non-profit research organization based in Tacoma, Washington. This 3-year grant, awarded on August 1, 2025, will support advanced biomedical research to characterize the genetic and functional basis of chemoresistance in small cell lung cancer. The research aims to transform healthcare for military service members and the broader public by...
The Department of the Army Medical Command awarded The Geneva Foundation a $909,510 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports advanced biomedical research focused on precision therapy for the eradication of brain metastatic breast cancer. The project, which runs from May 1, 2025 to April 30, 2028, will leverage The Geneva Foundation's expertise in biomedical research, clinical studies, and innovative medical...
The Geneva Foundation was awarded a $1,597,740 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from June 2022 to June 2026 to develop new methods for accessing extracellular vesicle MDM2 DNA cargo as a potential liposarcoma biomarker. Through support of basic, applied, and advanced biomedical research, the Military Medical Research and Development program aims to transform...
The U.S. Department of Defense's Defense Health Agency awarded a $488,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Geneva Foundation, a non-profit organization. The grant, awarded on July 1, 2024, supports research to investigate novel mechanisms of regulating the PAX3-FOXO1 fusion oncogene in rhabdomyosarcoma, a type of soft tissue cancer. The research aims to advance treatments for this rare and aggressive form of cancer, with a projected...
The Department of the Army awarded a $6,663,794 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Geneva Foundation, a non-profit medical research organization based in Tacoma, Washington. The grant, titled "PRECISIE RTD TRIAL: PRECISION WITH RETURN-TO-DUTY DECISIONS IN THE MILITARY", will fund advanced biomedical research focused on improving return-to-duty decisions for military personnel. The Geneva Foundation will collaborate with a...
The Geneva Foundation received a $453,029 Project Grant award from the Department of the Army Medical Command on February 1, 2021 to improve the therapeutic index of antibody drug conjugates targeting metastatic breast cancer. Funded through January 31, 2024 under the Military Medical Research and Development program (CFDA 12.420), this award will support the Foundation's work to transform healthcare and investigate medical solutions for the battlefield by developing more effective targeted...
The Department of the Army Medical Command awarded a $293,301 Project Grant to The Geneva Foundation for the period of August 1, 2022 through July 31, 2025. The grant supports research titled "MACHINE LEARNING-BASED INTEGRATED MORPHOLOGICAL AND MOLECULAR CHARACTERIZATION OF ADVANCED PROSTATE CANCER" under the Military Medical Research and Development program (CFDA 12.420). This program aims to transform military and public health care through innovative biomedical research that...
This federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $1,065,392.00 to The Geneva Foundation to conduct research on "LOCAL SLEEP IN THE WAKING BRAIN: A NOVEL TARGET FOR COGNITIVE FATIGUE". The project period runs from June 1, 2024 to May 31, 2028. As a non-profit research organization, The Geneva Foundation will perform foundational biomedical research investigating innovative treatments for...
The Defense Health Agency awarded a $325,650 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Geneva Foundation, a non-profit organization based in Tacoma, Washington. The grant, titled "Assessment of Changes in Human Blood Proteome Following Total Sleep Deprivation," will fund research to advance understanding of the impact of sleep deprivation on the human blood proteome over a 2-year period from March 1, 2025, to February 28, 2027. The...